publications
Selected publications
Triple-negative breast cancer-derived extracellular vesicles promote a hepatic pre-metastatic niche via a cascade of microenvironment remodeling. see details in our site
Heo W, Lee W, Cheun JH, Lee ES, Li S, Kim HS, Son HY, Kim JH, Woo YD, Chung DH, Yun J, Jung JG, Lee HB, Han W, Kim HK, Kim JI, Moon HG.
Mol Cancer Res. 2023 Apr 11:MCR-22-0673. doi: 10.1158/1541-7786.MCR-22-0673. Online ahead of print.
PMID: 37040163
Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial. see details in our site
Lee ES, Kim Y, Shin HC, Hwang KT, Min J, Kim MK, Ahn S, Jung SY, Shin H, Chung M, Yoo TK, Jung S, Woo SU, Kim JY, Noh DY, Moon HG.
Breast Cancer Res. 2023 Feb 14;25(1):20. doi: 10.1186/s13058-023-01616-5.
PMID: 36788595
AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells. see details in our site
Li S, Lee W, Heo W, Son HY, Her Y, Kim JI, Moon HG.
J Breast Cancer. 2023 Feb;26(1):60-76. doi: 10.4048/jbc.2023.26.e1. Epub 2022 Dec 16.
PMID: 36762781
An integrative approach for exploring the nature of fibroepithelial neoplasms. see details in our site
Yun J, Heo W, Lee ES, Na D, Kang W, Kang J, Chae J, Lee D, Lee W, Hwang J, Yoo TK, Hong BS, Son HY, Noh DY, Lee C, Moon HG, Kim JI.
Br J Cancer. 2022 Dec 16. doi: 10.1038/s41416-022-02064-2.
Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ. see details in our site
Lee SA, Lee Y, Ryu HS, Jang MJ, Moon WK, Moon HG, Lee SH.
Radiology. 2022 Jul 5:213174. doi: 10.1148/radiol.213174
Polo-Like Kinase 1 Regulates Chromosomal Instability and Paclitaxel Resistance in Breast Cancer Cells. see details in our site
Quan M, Oh Y, Cho SY, Kim JH, Moon HG.
J Breast Cancer. 2022 Jun;25(3):178-192. doi: 10.4048/jbc.2022.25.e28.
Comparative characterization of 3D chromatin organization in triple-negative breast cancers.
Kim T, Han S, Chun Y, Yang H, Min H, Jeon SY, Kim JI, Moon HG, Lee D.
Exp Mol Med. 2022 May 5. doi: 10.1038/s12276-022-00768-2
Association of Mammographic Density With Risk of Ipsilateral Breast Tumor Recurrence and Contralateral Breast Cancer. see details in our site
Cheun JH, Kim HK, Lee HB, Han W, Moon HG.
JAMA Surg. 2021 Nov 24. doi: 10.1001/jamasurg.2021.5859.
Calsequestrin 2 overexpression in breast cancer increases tumorigenesis and metastasis by modulating the tumor microenvironment. see details in our site
Kim JH, Lee ES, Yun J, Ryu HS, Kim HK, Ju YW, Kim K, Kim JI, Moon HG.
Mol Oncol. 2021 Nov 6. doi: 10.1002/1878-0261.13136.
JAK2 regulates paclitaxel resistance in triple negative breast cancers. see details in our site
Han J, Yun J, Quan M, Kang W, Jung JG, Heo W, Li S, Lee KJ, Son HY, Kim JH, Choi J, Noh DY, Na D, Ryu HS, Lee C, Kim JI, Moon HG.
J Mol Med (Berl). 2021 Oct 9. doi: 10.1007/s00109-021-02138-3. Online ahead of print.
Jeon SY, Kim KE, Kim EK, Han H, Lee HB, Han W, Noh DY, Moon HG.
J Oncol. 2021 Mar 12;2021:6636986. doi: 10.1155/2021/6636986. eCollection 2021.
Intensity of metastasis screening and survival outcomes in patients with breast cancer. see details in our site
Cheun JH, Jung J, Lee ES, Rhu J, Lee HB, Lee KH, Kim TY, Han W, Im SA, Noh DY, Moon HG.
Sci Rep. 2021 Feb 2;11(1):2851
S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell-cell interactions with adjacent breast cancer cells. see details in our site
Jo SH, Heo WH, Son HY, Quan M, Hong BS, Kim JH, Lee HB, Han W, Park Y, Lee DS, Kwon NH, Park MC, Chae J, Kim JI, Noh DY, Moon HG.
Sci Rep. 2021 Jan 14;11(1):1337
Dynamic and subtype-specific interactions between tumour burden and prognosis in breast cancer. see details in our site
Lee SB, Kim HK, Choi Y, Ju YW, Lee HB, Han W, Noh DY, Son BH, Ahn SH, Kim KS, Nam SJ, Kim EK, Park HY, Park WC, Lee JW, Moon HG.
Sci Rep. 2020 Sep 22;10(1):15445. doi: 10.1038/s41598-020-72033-3.
Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data. see details in our site
Choi SH, Kim KE, Park Y, Ju YW, Jung JG, Lee ES, Lee HB, Han W, Noh DY, Yoon HJ, Moon HG.
Breast. 2020 Aug 19;54:25-30. doi: 10.1016/j.breast.2020.08.003.
Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers. see details in our site
Hur S, Kim JH, Yun J, Ju YW, Han JM, Heo W, Kim K, Jeong K, Lee HB, Han W, Noh DY, Kim JI, Moon HG.
J Breast Cancer. 2020 Mar 9;23(2):162-170.
Tumor suppressor microRNA-204-5p regulates growth, metastasis, and immune microenvironment remodeling in breast cancer. see details in our site
Hong BS, Ryu HS, Kim N, Kim J, Lee E, Moon H, Kim KH, Jin MS, Kwon NH, Kim S, Kim D, Chung DH, Jeong K, Kim K, Kim KY, Lee HB, Han W, Yun J, Kim JI, Noh DY, Moon HG.
Cancer Res. 2019 Feb 8. pii: canres.0891.2018. doi: 10.1158/0008-5472.CAN-18-0891.
An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment. see details in our site
Yoo TK, Chang JM, Shin HC, Han W, Noh DY, Moon HG.
BMC Cancer. 2017 May 31;17(1):389. doi: 10.1186/s12885-017-3380-8.
Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism. see details in our site
Lee J, Hong BS, Ryu HS, Lee HB, Lee M, Park IA, Kim J, Han W, Noh DY, Moon HG.
PLoS One. 2017 Mar 23;12(3):e0174126. doi: 10.1371/journal.pone.0174126. eCollection 2017 Mar 23.
The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities. see details in our site
Han J, Lee HB, Lee ES, Kang YJ, Kim Y, Choi J, Rhu J, Shin HC, Han W, Noh DY, Moon HG.
PLoS One. 2017 Mar 21;12(3):e0173721. doi: 10.1371/journal.pone.0173721. eCollection 2017 Mar 21.
Identifying the potential long-term survivors among breast cancer patients with distant metastasis. see details in our site
Lee ES, Jung SY, Kim JY, Kim JJ, Yoo TK, Kim YG, Lee KS, Lee ES, Kim EK, Min JW, Han W, Noh DY, Moon HG.
Ann Oncol. 2016 Jan 28. pii: mdw036.
The Roles of Modern Breast Imaging Techniques for Evaluation of Lobular Carcinoma In Situ of the Breast. see details in our site
Shin H, Lee HB, Han W, Noh DY, Moon HG.
J Breast Disease 2015 DOI: http://dx.doi.org/10.14449/jbd.2015.3.2.71
The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers. see details in our site
Moon HG, Kim N, Jeong S, Lee M, Moon H, Kim J, Yoo TK, Lee HB, Kim J, Noh DY, Han W.
PLoS One. 2015 Dec 15;10(12):e0143811. doi: 10.1371/journal.pone.0143811. eCollection 2015.
Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers. see details in our site
Moon HG, Oh K, Lee J, Lee M, Kim JY, Yoo TK, Seo MW, Park AK, Ryu HS, Jung EJ, Kim N, Jeong S, Han W, Lee DS, Noh DY.
Breast Cancer Res Treat. 2015 Oct 5.
Reduced proliferation in breast cancer cells contacting the neighboring adipocytes in human breast cancer tissues. see details in our site
Ryu HS, Lee HB, Han W, Noh DY, Moon HG.
Breast Cancer Res. 2015 Jul 2;17(1):90
Moon HG, Han W, Kim JY, Kim SJ, Yoon JH, Oh SJ, Yu JH, Noh DY.
Ann Oncol. 2013 Sep;24(9):2298-304.
Moon HG, Han W, Ahn SK, Cho N, Moon WK, Im SA, Park IA, Noh DY.
Ann Surg. 2013 Jan;257(1):133-7.
Moon HG, Yi JK, Kim HS, Lee HY, Lee KM, Yi M, Ahn S, Shin HC, Ju JH, Shin I, Han W, Noh DY.
BMC Cancer. 2012 Dec 10;12:585
Moon HG, Im SA, Han W, Oh DY, Han SW, Keam B, Park IA, Chang JM, Moon WK, Cho N, Noh DY.
Breast Cancer Res Treat. 2012 Aug;134(3):1133-40.
NFIB is a potential target for estrogen receptor-negative breast cancers.
Moon HG, Hwang KT, Kim JA, Kim HS, Lee MJ, Jung EM, Ko E, Han W, Noh DY.
Mol Oncol. 2011 Dec;5(6):538-44
Up-regulation of RhoGDI2 in human breast cancer and its prognostic implications.
Moon HG, Jeong SH, Ju YT, Jeong CY, Lee JS, Lee YJ, Hong SC, Choi SK, Ha WS, Park ST, Jung EJ.
Cancer Res Treat. 2010 Sep;42(3):151-6.
Moon HG, Han W, Noh DY.
J Clin Oncol. 2010 Apr 1;28(10):1692-9
Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society.
Moon HG, Han W, Noh DY.
J Clin Oncol. 2009 Dec 10;27(35):5899-905
Moon HG, Han W, Lee JW, Ko E, Kim EK, Yu JH, Kang SY, Moon WK, Cho N, Park IA, Oh DY, Han SW, Im SA, Noh DY.
Ann Oncol. 2009 Apr;20(4):636-41.